Cargando…
Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
OBJECTIVE: This study aimed to evaluate systemic thrombolysis experiences with recombinant tissue plasminogen activator (rtPA). MATERIALS AND METHODS: Retrospective data were collected from 13 Turkish pediatric hematology centers. The dose and duration of rtPA treatment, concomitant anticoagulant tr...
Autores principales: | Zengin, Emine, Sarper, Nazan, Yazal Erdem, Arzu, Odaman Al, Işık, Sezgin Evim, Melike, Yaralı, Neşe, Belen, Burcu, Akçay, Arzu, Türedi Yıldırım, Ayşen, Karapınar, Tuba Hilkay, Güneş, Adalet Meral, Aylan Gelen, Sema, Ören, Hale, Olcay, Lale, Baytan, Birol, Gülen, Hüseyin, Öztürk, Gülyüz, Orhan, Mehmet Fatih, Oymak, Yeşim, Akpınar, Sibel, Tüfekçi, Özlem, Albayrak, Meryem, Tatlı Güneş, Burçak, Canpolat, Aylin, Özbek, Namık |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656121/ https://www.ncbi.nlm.nih.gov/pubmed/34431642 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0038 |
Ejemplares similares
-
Health-Related Quality of Life, Depression, Anxiety, and Self-Image in Acute Lymphocytic Leukemia Survivors
por: Baytan, Birol, et al.
Publicado: (2016) -
Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura
por: Evim, Melike Sezgin, et al.
Publicado: (2014) -
Assessment of Health-Related Quality of Life in Pediatric Acute Lymphoblastic Leukemia Survivors: Perceptions of Children, Siblings, and Parents
por: Kızmazoğlu, Deniz, et al.
Publicado: (2019) -
Cerebellar Granulocytic Sarcoma: A Case Report
por: Baytan, Birol, et al.
Publicado: (2012) -
Clinical characteristics of a Turkish family with congenital erythrocytosis due to an EPOR mutation: Is routine phlebotomy indicated in children and adolescents?
por: Sarper, Nazan, et al.
Publicado: (2020)